694 related articles for article (PubMed ID: 24171182)
1. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study.
Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME
J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182
[TBL] [Abstract][Full Text] [Related]
2. Effect of comorbid migraine on propranolol efficacy for painful TMD in a randomized controlled trial.
Tchivileva IE; Ohrbach R; Fillingim RB; Lim PF; Giosia MD; Ribeiro-Dasilva M; Campbell JH; Hadgraft H; Willis J; Arbes SJ; Slade GD
Cephalalgia; 2021 Jun; 41(7):839-850. PubMed ID: 33560875
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison between two different splint designs for temporomandibular disorder therapy.
Jokstad A; Mo A; Krogstad BS
Acta Odontol Scand; 2005 Aug; 63(4):218-26. PubMed ID: 16040444
[TBL] [Abstract][Full Text] [Related]
6. Headache and symptoms of temporomandibular disorder: an epidemiological study.
Gonçalves DA; Bigal ME; Jales LC; Camparis CM; Speciali JG
Headache; 2010 Feb; 50(2):231-41. PubMed ID: 19751369
[TBL] [Abstract][Full Text] [Related]
7. Effects of massage therapy and occlusal splint therapy on mandibular range of motion in individuals with temporomandibular disorder: a randomized clinical trial.
Gomes CA; Politti F; Andrade DV; de Sousa DF; Herpich CM; Dibai-Filho AV; Gonzalez Tde O; Biasotto-Gonzalez DA
J Manipulative Physiol Ther; 2014; 37(3):164-9. PubMed ID: 24387891
[TBL] [Abstract][Full Text] [Related]
8. Effects of occlusal splint therapy in patients with migraine or tension-type headache and comorbid temporomandibular disorder: A randomized controlled trial.
Saha FJ; Pulla A; Ostermann T; Miller T; Dobos G; Cramer H
Medicine (Baltimore); 2019 Aug; 98(33):e16805. PubMed ID: 31415392
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
10. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders.
Franco AL; Gonçalves DA; Castanharo SM; Speciali JG; Bigal ME; Camparis CM
J Orofac Pain; 2010; 24(3):287-92. PubMed ID: 20664830
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment of temporomandibular disorders (TMD) in patients with cervicogenic headache: a single-blind, randomized controlled study.
von Piekartz H; Lüdtke K
Cranio; 2011 Jan; 29(1):43-56. PubMed ID: 21370769
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome of headache after occlusal appliance therapy in a randomised controlled trial among patients with temporomandibular disorders of mainly arthrogenous origin.
Ekberg E; Vallon D; Nilner M
Swed Dent J; 2002; 26(3):115-24. PubMed ID: 12425225
[TBL] [Abstract][Full Text] [Related]
13. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
Silberstein S; Goode-Sellers S; Twomey C; Saiers J; Ascher J
Cephalalgia; 2013 Jan; 33(2):101-11. PubMed ID: 23165696
[TBL] [Abstract][Full Text] [Related]
15. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
16. The influence of myofascial temporomandibular disorder pain on the pressure pain threshold of women during a migraine attack.
Pinto Fiamengui LM; Freitas de Carvalho JJ; Cunha CO; Bonjardim LR; Fiamengui Filho JF; Conti PC
J Orofac Pain; 2013; 27(4):343-9. PubMed ID: 24171184
[TBL] [Abstract][Full Text] [Related]
17. Temporomandibular disorders are differentially associated with headache diagnoses: a controlled study.
Gonçalves DA; Camparis CM; Speciali JG; Franco AL; Castanharo SM; Bigal ME
Clin J Pain; 2011 Sep; 27(7):611-5. PubMed ID: 21368664
[TBL] [Abstract][Full Text] [Related]
18. Effect of a traditional syrup from Citrus medica L. fruit juice on migraine headache: A randomized double blind placebo controlled clinical trial.
Jafarpour M; Yousefi G; Hamedi A; Shariat A; Salehi A; Heydari M
J Ethnopharmacol; 2016 Feb; 179():170-6. PubMed ID: 26721220
[TBL] [Abstract][Full Text] [Related]
19. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
20. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
